Lenz Therapeutics Stock Forecast

Sell candidate since May 29, 2026 Loss -28.02%

The Lenz Therapeutics, Inc. stock price fell by -4.92% on the last day (Monday, 6th Jul 2026) from $5.89 to $5.60. During the last trading day the stock fluctuated 10.89% from a day low at $5.24 to a day high of $5.81. The price has fallen in 7 of the last 10 days and is down by -8.94% for this period. Volume has increased on the last day by 282 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 1 million shares were bought and sold for approximately $7.25 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -40.60% during the next 3 months and, with a 90% probability hold a price between $2.99 and $4.19 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

LENZ Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, June 25, 2026, and so far it has risen 1.63%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Lenz Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $5.72 and $6.68. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Lenz Therapeutics, Inc. stock

Lenz Therapeutics, Inc. finds support from accumulated volume at $5.58 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.570 between high and low, or 10.89%. For the last week, the stock has had daily average volatility of 7.28%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (LENZ) For The Upcoming Trading Day Of Tuesday 7th

For the upcoming trading day on Tuesday, 7th we expect Lenz Therapeutics, Inc. to open at $5.55, and during the day (based on 14 day Average True Range), to move between $5.37 and $5.83, which gives a possible trading interval of +/-$0.468 (+/-8.72%) up or down from last closing price. If Lenz Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 8.72% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $5.58 (0.36%) than the resistance at $5.68 (1.43%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Lenz Therapeutics, Inc. stock A Buy?

Lenz Therapeutics, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.883 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 7, 2026 - $5.55 ( 0.95%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk